DD0 (N = 234) | DD1 (N = 83) | LD (N = 152) | P value DD0 v DD1 | P value DD0 v LD | P value DD1 v LD | |
---|---|---|---|---|---|---|
Recipient Characteristics | ||||||
Recipient age at transplant, years mean ± SD (range) | 58.5 ± 11 (22–79) | 52.8 ± 13 (24–75) | 46.6 ± 13 (17–74) | < 0.001 | < 0.0001 | 0.001 |
Male N (%) | 149 (63.7) | 53 (63.9) | 93 (68.4) | 0.976 | 0.358 | 0.490 |
Race/Ethnicity N (%) | ||||||
Caucasian | 82 (35) | 32 (39) | 87 (57) | 0.566 | < 0.0001 | 0.009 |
Black | 42 (18) | 11 (13) | 7 (5) | 0.324 | 0.0002 | 0.017 |
East Asian | 55 (24) | 14 (17) | 25 (17) | 0.208 | 0.094 | 0.893 |
South Asian | 50 (21) | 22 (27) | 31 (20) | 0.337 | 0.859 | 0.311 |
Hispanic | 5 (2) | 4 (3) | 2 (1) | 0.248 | 0.491 | 0.148 |
Dialysis duration (months) | 70.3 ± 32 | 60 ± 26 | 22.1 ± 17 | 0.012 | < 0.0001 | < 0.0001 |
Peak PRA (%) | 28 ± 33 | 42 ± 38 | 16 ± 27 | 0.004 | 0.002 | < 0.0001 |
Smoking N (%) | 55 (23.5) | 33 (39.8) | 50 (36.8) | 0.004 | 0.006 | 0.657 |
CVD N (%) | 102 (43.6) | 34 (40.9) | 49 (36.0) | 0.677 | 0.153 | 0.465 |
Cause of End Stage Kidney Disease N (%) | ||||||
Diabetes | 65 (28) | 14 (17) | 24 (16) | 0.048 | 0.011 | 0.893 |
Hypertension | 19 (8) | 5 (6) | 8 (5) | 0.535 | 0.280 | 0.782 |
Glomerulonephritis | 72 (31) | 35 (42) | 54 (35) | 0.059 | 0.370 | 0.309 |
Polycystic kidney disease | 18 (8) | 10 (12) | 23 (15) | 0.229 | 0.019 | 0.484 |
Congenital | 15 (6) | 2 (3) | 18 (12) | 0.131 | 0.073 | 0.010 |
Interstitial nephritis | 6 (2) | 6 (7) | 7 (4) | 0.062 | 0.249 | 0.374 |
Others | 39 (17) | 11 (13) | 18 (12) | 0.463 | 0.201 | 0.745 |
Donor characteristics | ||||||
Donor age, years mean ± SD | 49.5 ± 15 | 48.7 ± 13 | 42.8 ± 12 | 0.673 | < 0.0001 | 0.001 |
NDD/DCD N (%) | 171(73)/ 63(27) | 63(76)/ 20(24) | NA | 0.659 | NA | NA |
SCD/ECD N (%) | 138(59)/ 96(41) | 55(66)/ 28(34) | NA | 0.295 | NA | NA |
Terminal serum creatinine (umol/L) mean ± SD | 65 ± 22 | 68 ± 28 | NA | 0.611 | NA | NA |
Cold Ischemia Time (minutes) mean ± SD | 619 ± 240 | 622 ± 261 | NA | 0.23 | NA | NA |